Drugs / XQ-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06918366 | Aug 2024 → Mar 2025 overdue | — | Brilliant Inspiration Biotherapeutics | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XQ-001 | “Inhaled XQ-001” NCT06918366 ↗ |
| Route | Inhaled | “Inhaled XQ-001” NCT06918366 ↗ |